The Clinical and Economic Efficacy of FDG-PET in the Diagnosis and Management of Breast Cancer

Bibliographic Information

Other Title
  • 乳腺腫瘍におけるFDG-PET検査の有用性と医療経済効果
  • 乳腺腫瘍におけるFDG-PET検査の有用性と医療経済効果--アンケート調査の集計結果による検討
  • ニュウセン シュヨウ ニ オケル FDG PET ケンサ ノ ユウヨウセイ ト イリョウ ケイザイ コウカ アンケート チョウサ ノ シュウケイ ケッカ ニ ヨル ケントウ
  • ―アンケート調査の集計結果による検討―
  • —An Analysis Based on the Results of Questionnaire—

Search this article

Abstract

This study was performed by the PET working group under Japan Radioisotope Association. On the basis of the results of survey, clinical and economic efficacy of PET using 2- [F-18] -fluoro-2-deoxy-D-glucose (FDG) in the diagnosis and management of breast cancer was analysed retrospectively.<BR>The accuracy of FDG-PET resulted in high value (94%) in the regional stage of breast cancer. FDG-PET also could potentially detect axillary lymph node metastases and the accuracy was 85%. By reducing axillary lymph node dissection in the nearly 50% of candidates for breast conservation therapy with negative PET scans, FDG-PET would be expected to save 1.6 billion yen per year.

Journal

  • RADIOISOTOPES

    RADIOISOTOPES 49 (2), 51-57, 2000

    Japan Radioisotope Association

Citations (4)*help

See more

References(30)*help

See more

Details 詳細情報について

Report a problem

Back to top